Jeff Heiser

Company: BA Sciences

Job title: Chief Scientific Officer - Microbial & Advanced Therapeutic Platforms

Seminars:

Implementation of Phase Appropriate mRNA Analytics in a Contract Testing Environment: Balancing the Development & Qualification Approach in a mRNA Program 10:00 am

The analytical requirements for characterization of mRNA Drug Substance and Drug Products have been defined by the USP as well as sponsor companies participating in early phase clinical trials  Balancing the effort spent on method development and qualification/validation is critical to keeping with timelines and controlling analytical costs  How to utilize a suite of mRNA…Read more

day: Conference Day One